Abstract
Potential anticancer therapy with the fumagillin analog TNP-470 was investigated in the present project using subcutaneously growing rhabdomyosarcomas in rats. Specifically, influences of different tumor sizes at the start of treatment as well as dose/schedules were evaluated with this angiogenesis inhibitor The results show a significant (p = less than or equal to0.01) reduction of the growth rare, even for relatively large-sized (>7 cm(3)) tumors, when 50 m/kg TNP-470 was used every other day for up to 3 or 5 injections. With 30 mg/kg TNP-470 injections, effects were seen only with tumors measuring
| Original language | English |
|---|---|
| Pages (from-to) | 35-40 |
| Number of pages | 6 |
| Journal | Cancer Investigation |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2001 |
| Externally published | Yes |
Keywords
- ANGIOGENESIS INHIBITOR
- METASTASIS
- FUMAGILLIN
- CANCER
Fingerprint
Dive into the research topics of 'Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver